We are live on ! Find out more
BC

Burleson & Co Portfolio holdings

AUM $401M
1-Year Est. Return 25.44%
This Fund
S&P 500
This Quarter Est. Return
-8.63%
1 Year Est. Return
-25.44%
3 Year Est. Return
+49.06%
5 Year Est. Return
+69.5%
10 Year Est. Return
AUM
$623M
AUM Growth
-$63.6M
Cap. Flow
+$19.8M
Cap. Flow %
3.18%
Top 10 Hldgs %
41.05%
Holding
481
New
84
Increased
124
Reduced
77
Closed
28

Top Sells

Rank Stock Value
1
BA icon
Boeing
BA
+$21.9M
2
AAPL icon
Apple
AAPL
+$12.9M
3
NVDA icon
NVIDIA
NVDA
+$8.96M
4
AMZN icon
Amazon
AMZN
+$5.96M
5
SNOW icon
Snowflake
SNOW
+$5.22M

Sector Composition

Rank Sector Weight
1 Technology 27.26%
2 Consumer Discretionary 16.77%
3 Communication Services 9.98%
4 Financials 8.47%
5 Healthcare 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNH icon
51
UnitedHealth
UNH
$375B
$2.88M 0.46%
5,653
+5,350
+1,766% +$2.58M
V icon
52
Visa
V
$688B
$2.86M 0.46%
12,907
+12,293
+2,002% +$2.66M
WMT icon
53
Walmart Inc
WMT
$894B
$2.85M 0.46%
57,390
+55,269
+2,606% +$2.59M
JNJ icon
54
Johnson & Johnson
JNJ
$621B
$2.67M 0.43%
15,079
+102
+0.7% +$17.4K
VBK icon
55
Vanguard Morningstar Small-Cap Growth ETF
VBK
$24B
$2.61M 0.42%
10,534
+1,652
+19% +$407K
VNQ icon
56
Vanguard Real Estate ETF
VNQ
$39.2B
$2.6M 0.42%
24,004
+969
+4% +$103K
VOE icon
57
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24B
$2.5M 0.4%
16,740
+2,005
+14% +$295K
WBA
58
DELISTED
Walgreens Boots Alliance
WBA
$2.3M 0.37%
+51,363
New +$2.53M
BMRC icon
59
Bank of Marin Bancorp
BMRC
$472M
$2.3M 0.37%
65,496
+4
+0% +$146
VO icon
60
Vanguard Morningstar Mid-Cap ETF
VO
$109B
$2.29M 0.37%
38,520
-7,480
-16% -$439K
BMY icon
61
Bristol-Myers Squibb
BMY
$130B
$2.25M 0.36%
30,841
+203
+0.7% +$13.6K
VOT icon
62
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.9B
$2.25M 0.36%
10,100
+1,867
+23% +$412K
TIP icon
63
iShares TIPS Bond ETF
TIP
$14.5B
$2.1M 0.34%
16,890
-2,177
-11% -$274K
INTC icon
64
Intel
INTC
$510B
$2.09M 0.34%
42,194
+32
+0.1% +$1.59K
XLK icon
65
State Street Technology Select Sector SPDR ETF
XLK
$122B
$1.99M 0.32%
25,076
-5,464
-18% -$429K
BNDX icon
66
Vanguard Total International Bond ETF
BNDX
$82.3B
$1.8M 0.29%
34,254
-8,287
-19% -$445K
CVX icon
67
Chevron
CVX
$371B
$1.73M 0.28%
10,623
-73
-0.7% -$10.5K
AMAT icon
68
Applied Materials
AMAT
$424B
$1.68M 0.27%
12,746
+8
+0.1% +$1.1K
UPS icon
69
United Parcel Service
UPS
$91.5B
$1.68M 0.27%
7,808
+9
+0.1% +$1.91K
CAT icon
70
Caterpillar
CAT
$401B
$1.62M 0.26%
7,289
+53
+0.7% +$11.1K
PEP icon
71
PepsiCo
PEP
$189B
$1.58M 0.25%
9,421
+48
+0.5% +$8.06K
SCHX icon
72
Schwab US Large- Cap ETF
SCHX
$74.1B
$1.53M 0.25%
85,497
-44,031
-34% -$779K
ABT icon
73
Abbott
ABT
$183B
$1.49M 0.24%
12,569
RH icon
74
RH
RH
$3.7B
$1.41M 0.23%
4,321
+1,025
+31% +$410K
QNCX icon
75
Quince Therapeutics
QNCX
$28.2M
$1.39M 0.22%
1,123
+42
+4% +$57.2K

Similar funds

Burleson & Co's Q1 2022 Portfolio in Review

As of Q1 2022, Burleson & Co held 481 positions worth $623M, down 9.3% from $687M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Burleson & Co deployed $19.8M of net new capital in Q1 2022, opening 84 new positions and adding to 124 existing holdings. Its largest new stake was Walgreens Boots Alliance: 51,363 shares worth $2.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 34% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Boeing, an estimated $21.9M trimmed.

  • Burleson & Co's largest Q1 2022 buy was Walgreens Boots Alliance: 51,363 shares worth $2.3M.
  • Burleson & Co added most to Berkshire Hathaway Class B in Q1 2022, an estimated $12.5M increase.
  • Burleson & Co's biggest Q1 2022 reduction was Boeing, cutting an estimated $21.9M.
  • Burleson & Co fully exited ARK Innovation ETF in Q1 2022, selling an estimated $4.8M.
  • Burleson & Co's ten largest holdings make up 41% of its $623M portfolio in Q1 2022.
  • Burleson & Co opened 84 new positions and closed 28 in Q1 2022.
  • Burleson & Co's portfolio value fell 9.3% quarter-over-quarter to $623M.

Based on Burleson & Co's 13F filing for Q1 2022, filed 25 Apr 2022.